Organisation paid for research Program year 2022 Source: CMS Open Payments

Amici-Gi LLC

Neither a doctor nor a teaching hospital

Research payments

$627,228

121 payments

Through program year 2022, Amici-Gi LLC is reported as receiving $627,228 in research payments, across 121 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2022	Research	$38,743	8
2021	Research	$138,483	19
2020	Research	$141,676	33
2019	Research	$308,326	61

Breakdown

Who paid Research payments · program years 2019–2022

Intercept Pharmaceuticals, Inc. $627,228 121 payments

Studies the money was for Research payments · program years 2019–2022

1011866 $400,305 72 payments
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment (REGENERATE) $138,483 19 payments
1009742 $49,697 22 payments
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment (REGENERATE) $33,434 5 payments
Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (REVERSE) $5,309 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.